Lamotrigine Has Minimal Direct Effects on Menstrual Cycles
Lamotrigine itself does not cause menstrual irregularities or disrupt normal menstrual cycle function in women of reproductive age. 1 Unlike valproate, which is specifically associated with increased risk of polycystic ovarian syndrome (PCOS) and menstrual disturbances, lamotrigine has minimal impact on hormonal regulation and endocrine function.
Key Evidence on Lamotrigine and Menstrual Function
Direct Effects on the Menstrual Cycle
The most robust evidence demonstrates that:
- Natural hormonal fluctuations during the menstrual cycle do not significantly affect lamotrigine levels 2, 3
- Studies measuring lamotrigine concentrations throughout complete menstrual cycles in women not using hormonal contraception found no clinically relevant changes associated with physiological hormonal fluctuations 3
- One study showed a notable but not statistically significant 31.3% median decline during the mid-luteal phase compared to early-mid follicular phase, but this did not reach clinical significance 4
Contrast with Other Antiseizure Medications
This is an important distinction from other antiseizure medications:
- Valproate is specifically associated with 1.95-fold higher incidence of PCOS compared to other antiseizure medications, particularly when initiated at young age 1
- Enzyme-inducing medications (carbamazepine, phenytoin, phenobarbital) can cause menstrual disturbances through alterations in sex hormone metabolism 5
- Lamotrigine stands out as having minimal endocrine side effects 6
The Critical Interaction: Hormonal Contraceptives
While lamotrigine doesn't affect the menstrual cycle directly, there is a clinically significant bidirectional interaction with combined oral contraceptives that warrants careful attention:
How Oral Contraceptives Affect Lamotrigine
Combined oral contraceptives containing estrogen markedly reduce lamotrigine levels (+++, strong reduction ≥50%) through induction of hepatic glucuronidation 1:
- Mean lamotrigine clearance increases from 49 L/24 hours in women not using contraceptives to 126 L/24 hours in women using combined oral contraceptives 2
- During the pill-free week, lamotrigine levels can increase by 54% (range 29%-129%) above baseline 2
- Levels return to baseline within a mean of 8 days after restarting active pills 2
- This creates substantial intracycle variability with risks of subtherapeutic exposure during active hormone phases and potential toxicity during hormone-free intervals 7
Clinical Recommendations for Contraception
Prefer intrauterine devices (IUD) or levonorgestrel-containing IUD (LCIUD) in women taking lamotrigine 1. If combined oral contraceptives are used:
- Monitor lamotrigine levels closely
- Adjust lamotrigine dose when starting or stopping oral contraceptives
- Consider continuous (no pill-free week) regimens to minimize fluctuations
- Be aware that different progestins have varying effects: drospirenone and levonorgestrel appear to reduce lamotrigine levels more than gestodene 8
Does Lamotrigine Affect Contraceptive Efficacy?
The evidence is reassuring but uncertain:
- Lamotrigine may modestly reduce progestin concentrations, but the clinical relevance for contraceptive efficacy remains uncertain 1
- One study found no effect of lamotrigine on several progestins, arguing against loss of contraception safety 8
- The guideline classification is "uncertain" regarding whether lamotrigine reduces oral contraceptive efficacy 1
Fertility Considerations
Lamotrigine does not impair fertility 1. In women with epilepsy experiencing infertility or menstrual irregularities:
- Evaluate for PCOS or ovulatory dysfunction
- Consider that epilepsy itself and psychosocial factors contribute more to reduced birth rates than medication effects
- If menstrual irregularities occur, look for other causes rather than attributing them to lamotrigine
Practical Clinical Approach
When counseling women of reproductive age on lamotrigine:
- Reassure that lamotrigine does not cause menstrual irregularities or hormonal dysfunction
- Address contraception proactively: Recommend IUD as first-line; if oral contraceptives preferred, establish baseline lamotrigine levels and monitor closely
- If menstrual irregularities develop: Investigate other causes including PCOS, hypothalamic amenorrhea, thyroid dysfunction, or effects of other medications
- For women planning pregnancy: Lamotrigine is a first-line option with favorable fetal outcomes 9
Common Pitfalls to Avoid
- Do not attribute menstrual irregularities to lamotrigine without investigating other causes, particularly if the patient is also taking valproate or has other risk factors for PCOS
- Do not overlook the contraceptive interaction: Failure to adjust lamotrigine dosing when starting oral contraceptives can lead to breakthrough seizures
- Do not assume all hormonal contraceptives interact equally: Progestin-only methods and non-hormonal IUDs have more favorable profiles with lamotrigine 7